ÂÜÀòÂÒÂ×

Dr. Nancy Boman is Chief Regulatory Officer of Adicet Bio. With nearly 30 years of experience in the biotech and pharmaceutical industry most recently in the cell and gene therapy space, Dr. Boman has expertise in Regulatory strategy and operations, clinical development and CMC. She has led more than 15 drug marketing applications in various indications including in hematologic malignancies, such as non-Hodgkin’s lymphoma and in solid tumors.

Before joining Adicet, Dr. Boman served as Chief Regulatory Officer at Encoded Therapeutics where she built and oversaw all aspects of the Regulatory and QA departments for the company’s gene therapy candidates. Prior to that, Dr. Boman served as Chief Regulatory Officer at AveXis Inc. (now Novartis Gene Therapies) and has also held senior positions in regulatory affairs and clinical development at Alder BioPharmaceuticals, Cell Therapeutics, Genentech, and Amgen.

Dr. Boman received her M.D. in Human Medicine, her Ph.D. in Biochemistry, and B.Sc. in General Science from The University of British Columbia.